BRIEF-Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles

Reuters
Nov 10
BRIEF-Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles

Nov 10 (Reuters) - Armata Pharmaceuticals Inc ARMP.A:

  • ARMATA PHARMACEUTICALS INC - COMMISSIONS CGMP MANUFACTURING FACILITY IN LOS ANGELES

  • ARMATA PHARMACEUTICALS INC - FDA NOTIFIED OF PRODUCTION COMMENCEMENT; NO ISSUES REPORTED

Source text: ID:nPn56dVy5a

Further company coverage: ARMP.A

((reuters.briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10